Catalyst Wire Dossier Catalyst Wire Dossier

TIMOPTIC-XE

TIMOLOL MALEATE · Bausch & Lomb Incorporated
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TIMOPTIC-XE, covering 2011-09-30 to 2018-07-16. Get the full timeline:

Most recent: FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)

See pricing